Biotech · Private company
Biocompatibles UK Ltd
Track this companyFree. Adds Biocompatibles UK Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials101 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials10
- TheraSphere With Durvalumab and Tremelimumab for HCCPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 3, 2023ClinicalTrials.gov NCT05063565 · fetched Nov 12, 2026
- Cryoablation With Pembrolizumab Or Avelumab In Urothelial CarcinomaPHASE2 · COMPLETED · started Jun 4, 2021ClinicalTrials.gov NCT04701918 · fetched Nov 12, 2026
- Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal CancerPHASE1 · TERMINATED · started Oct 5, 2020ClinicalTrials.gov NCT04108481 · fetched Nov 12, 2026
- Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES)NA · COMPLETED · started Jan 10, 2020ClinicalTrials.gov NCT04197336 · fetched Nov 12, 2026
- RadioEmbolization for the ADvancement of Y90 Glass Microspheres RegistryTERMINATED · started Feb 23, 2018ClinicalTrials.gov NCT03516695 · fetched Nov 12, 2026
- A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCCCOMPLETED · started Oct 31, 2016ClinicalTrials.gov NCT03295006 · fetched Nov 12, 2026
- Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal VeinPHASE3 · TERMINATED · started Feb 27, 2014ClinicalTrials.gov NCT01887717 · fetched Nov 12, 2026
- Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver CancerNA · COMPLETED · started Mar 1, 2012ClinicalTrials.gov NCT01556490 · fetched Nov 12, 2026
- Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal CancerNA · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01483027 · fetched Nov 12, 2026
- Therasphere for Unresectable Primary or Secondary Liver NeoplasiaNO_LONGER_AVAILABLEClinicalTrials.gov NCT02960620 · fetched Nov 12, 2026